| Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations JZ Liu, S Van Sommeren, H Huang, SC Ng, R Alberts, A Takahashi, ... Nature genetics 47 (9), 979-986, 2015 | 2459 | 2015 |
| Anti-inflammatory effects of resveratrol in patients with ulcerative colitis: a randomized, double-blind, placebo-controlled pilot study M Samsami-Kor, NE Daryani, PR Asl, A Hekmatdoost Archives of medical research 46 (4), 280-285, 2015 | 208 | 2015 |
| Gastrointestinal manifestations in patients with common variable immunodeficiency A Khodadad, A Aghamohammadi, N Parvaneh, N Rezaei, F Mahjoob, ... Digestive diseases and sciences 52, 2977-2983, 2007 | 169 | 2007 |
| Resveratrol supplementation and oxidative/anti-oxidative status in patients with ulcerative colitis: a randomized, double-blind, placebo-controlled pilot study M Samsamikor, NE Daryani, PR Asl, A Hekmatdoost Archives of medical research 47 (4), 304-309, 2016 | 143 | 2016 |
| Effect of oral naltrexone on pruritus in cholestatic patients F Mansour-Ghanaei, A Taheri, H Froutan, H Ghofrani, M Nasiri-Toosi, ... World journal of gastroenterology: WJG 12 (7), 1125, 2006 | 117 | 2006 |
| Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome E Barkhordari, N Rezaei, B Ansaripour, P Larki, M Alighardashi, ... Journal of clinical immunology 30, 74-79, 2010 | 113 | 2010 |
| Comparison of five diagnostic methods for Helicobacter pylori M Khalifehgholi, F Shamsipour, H Ajhdarkosh, NE Daryani, ... Iranian journal of microbiology 5 (4), 396, 2013 | 107 | 2013 |
| Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases G Jahanshahi, V Motavasel, A Rezaie, AA Hashtroudi, NE Daryani, ... Digestive Diseases and Sciences 49, 1752-1757, 2004 | 107 | 2004 |
| Emerging epidemic of inflammatory bowel disease in a middle income country: a nation-wide study from Iran MM Malekzadeh, H Vahedi, K Gohari, P Mehdipour, SG Sepanlou, ... Archives of Iranian medicine 19 (1), 0-0, 2016 | 100 | 2016 |
| A Triple Blinded, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis: a Pilot Study. S Rahimpour, M Nasiri-Toosi, H Khalili, NE Daryani, MK Nouri Taromlou, ... Journal of Gastrointestinal & Liver Diseases 25 (4), 2016 | 98 | 2016 |
| Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta‐analysis M Bashashati, N Rezaei, H Bashashati, A Shafieyoun, NE Daryani, ... Neurogastroenterology & Motility 24 (12), 1102-e566, 2012 | 97 | 2012 |
| Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study Z Yari, M Rahimlou, T Eslamparast, N Ebrahimi-Daryani, H Poustchi, ... International journal of food sciences and nutrition 67 (4), 461-469, 2016 | 96 | 2016 |
| Cytokines and irritable bowel syndrome: where do we stand? M Bashashati, N Rezaei, CN Andrews, CQ Chen, NE Daryani, ... Cytokine 57 (2), 201-209, 2012 | 95 | 2012 |
| Gender role in irritable bowel syndrome: a comparison of irritable bowel syndrome module (ROME III) between male and female patients SJ Anbardan, NE Daryani, SM Fereshtehnejad, STT Vakili, MR Keramati, ... Journal of neurogastroenterology and motility 18 (1), 70, 2012 | 81 | 2012 |
| The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis A Farnood, N Naderi, SJM Moghaddam, B Noorinayer, F Firouzi, ... International journal of colorectal disease 22, 999-1003, 2007 | 79 | 2007 |
| Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis A Moayyeri, NE Daryani, H Bahrami, B Haghpanah, A NAYYER‐HABIBI, ... Journal of gastroenterology and hepatology 20 (3), 366-370, 2005 | 76 | 2005 |
| Evaluation of health related quality of life in irritable bowel syndrome patients R Jamali, A Jamali, M Poorrahnama, A Omidi, B Jamali, N Moslemi, ... Health and Quality of Life Outcomes 10, 1-6, 2012 | 75 | 2012 |
| Alterations in Salivary Antioxidants, Nitric Oxide, and Transforming Growth Factor‐β1 in Relation to Disease Activity in Crohn's Disease Patients A Rezaie, F Ghorbani, A Eshghtork, MJ Zamani, G Dehghan, B Taghavi, ... Annals of the New York Academy of Sciences 1091 (1), 110-122, 2006 | 75 | 2006 |
| The Antimicrobial Effects and Metabolomic Footprinting of Carboxyl-Capped Bismuth Nanoparticles Against Helicobacter pylori P Nazari, R Dowlatabadi-Bazaz, MR Mofid, MR Pourmand, NE Daryani, ... Applied biochemistry and biotechnology 172, 570-579, 2014 | 70 | 2014 |
| Association of dietary fiber, fruit, and vegetable consumption with risk of inflammatory bowel disease: a systematic review and meta-analysis A Milajerdi, N Ebrahimi-Daryani, LA Dieleman, B Larijani, A Esmaillzadeh Advances in Nutrition 12 (3), 735-743, 2021 | 69 | 2021 |
